TESTING A
NEW TREATMENT
FOR WEST NILE
"This new drug therapy has the potential of neutralizing the West Nile virus and could possibly reduce or prevent complications associated with the neuroinvasive disease."
Russell Bartt, MD, neurologist
Neurological and infectious disease experts at Rush are testing a new drug treatment for people infected with West Nile virus. Rush is the only site in the Midwest enrolling patients in the $50 million, NIH-funded, Phase II clinical trial called PARADIGM.